Sunday, 5 Oct 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    04/10/2025
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    04/10/2025
    10 Icons Who Inspire Change: A Celebration of Vision, Commitment & Legacy
    10 Icons Who Inspire Change: A Celebration of Vision, Commitment & Legacy
    03/10/2025
    Bitget CEO Gracy Chen Supports Inaugural UNICEF Game Jam
    Bitget CEO Gracy Chen Supports Inaugural UNICEF Game Jam
    03/10/2025
    Feedzai Accelerates AI-led Financial Crime Prevention with New Investment Round that Grows Company’s Valuation to  Billion
    Feedzai Accelerates AI-led Financial Crime Prevention with New Investment Round that Grows Company’s Valuation to $2 Billion
    02/10/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  • june
  • announced
  • today
  •  and
  • july
  •  the
  • company
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNews Wire
Last updated: 14/09/2025 1:32 PM
GlobeNews Wire
Share
2 Min Read
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SHARE
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 12, 2025 16:30 ET  | Source: Fulcrum Therapeutics, Inc.

CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

Fulcrum granted the new employee 35,000 options to purchase shares of the company’s common stock at an exercise price of $7.27 per share, the closing price per share of Fulcrum’s common stock as reported on the grant effective date, September 8, 2025. Each option has a ten-year term and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee’s start date and an additional 6.25% of the shares vesting in equal quarterly installments over the twelve successive quarters following the first anniversary, subject to the applicable employee’s continued service with the company through the applicable vesting dates.

About Fulcrum Therapeutics

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s lead clinical program is pociredir, a small molecule designed to increase expression of fetal hemoglobin for the treatment of SCD. Fulcrum uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. For more information, visit http://www.fulcrumtx.com and follow us on X (@FulcrumTx) and LinkedIn.

Contact:

Kevin Gardner
LifeSci Advisors, LLC
kgardner@lifesciadvisors.com
617-283-2856

Midea Group Reports a Record-Breaking Financial Performance in 2025 H1
Technology sector anchors ~40% office leasing while global enterprises expand India operations: Colliers
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer’s Association International Conference (AAIC)
JUST ON SLEEP Officially Launches on Shopee Singapore, Redefining Sleep Safety and Wellness
FNZ launches Advisor AI to redefine advisor productivity and scale personalized advice
TAGGED:5635(c)(4)AdventureanniversaryapplicablecambridgecommoncompanycompanysdateemployeeemployeesfirstfulcrumgrantedgrantsincinducementlistingmassnasdaqNasdaq:FULCnewsoptionsperplanpricepurchasereportsruleseptseptembersharesharessourcestocktherapeuticsunderUS3596161097vesting
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Kids India 2025 starts off strong in Mumbai
Travel

Kids India 2025 starts off strong in Mumbai

25/09/2025

adidas Reimagines Equipment for the Course Focused on the Essentials and Nothing More

04/09/2025
Next Level Aviation Appoints Danny Budding as Senior Vice President of Sales – Global
Travel

Next Level Aviation Appoints Danny Budding as Senior Vice President of Sales – Global

02/10/2025
HeartCore Signs 15th Go IPO Contract
Tech

HeartCore Signs 15th Go IPO Contract

04/06/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?